Vendor review
Hangzhou Mandy Biotechnology reviews
Hangzhou Mandy Biotechnology reviews from 38 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is Hangzhou Mandy Biotechnology legit? See what its vials showed.
What the lab tests show
38 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Aug 5, 2026 | BPC-157 | 99.9 % | 4.18 mg of 5 mg (-16 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 99.9 % | 18.5 mg of 20 mg (-8 %) | Pass | View |
| Jun 22, 2026 | Retatrutide | 99.9 % | 27.4 mg of 30 mg (-9 %) | Pass | View |
| Jun 17, 2026 | Tirzepatide | 99.7 % | 22.9 mg of 20 mg (15 %) | Pass | View |
| Jun 17, 2026 | BPC-157 | 99.4 % | 10 mg of 10 mg (0 %) | Pass | View |
| Jun 16, 2026 | GHK-Cu | 99.9 % | 82.1 mg of 100 mg (-18 %) | Pass | View |
| May 28, 2026 | Tirzepatide | 30 mg | View | ||
| May 25, 2026 | Tirzepatide | 99.7 % | 31.4 mg of 30 mg (5 %) | Pass | View |
| May 8, 2026 | Retatrutide | 99.7 % | 15.1 mg of 15 mg (1 %) | Pass | View |
| Apr 30, 2026 | Retatrutide | 99.5 % | 9.8 mg of 10 mg (-2 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.6 % | 20.6 mg of 20 mg (3 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 99.9 % | 30.5 mg of 30 mg (2 %) | Pass | View |
| Mar 25, 2026 | Tirzepatide | 99.6 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Mar 6, 2026 | GHK-Cu | 99.8 % | 128 mg of 100 mg (28 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Mar 4, 2026 | BPC-157 | 99.75 % | 11.3 mg of 10 mg (13 %) | Pass | View |
| Mar 4, 2026 | Tirzepatide | 98.31 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Mar 3, 2026 | Tirzepatide | 99.9 % | 42.5 mg of 40 mg (6 %) | Pass | View |
| Mar 3, 2026 | Retatrutide | 99.28 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Feb 26, 2026 | Tirzepatide | 93.01 % | 31.4 mg of 30 mg (5 %) | Pass | View |
| Feb 22, 2026 | Retatrutide | 99.74 % | 21.7 mg of 20 mg (9 %) | Pass | View |
| Feb 20, 2026 | GHK-Cu | 99.9 % | 109 mg of 100 mg (9 %) | Pass | View |
| Feb 20, 2026 | GHK-Cu | 99.9 % | 84.4 mg of 100 mg (-16 %) | Pass | View |
| Feb 13, 2026 | Tirzepatide | 99.8 % | 9.55 mg of 10 mg (-4 %) | Pass | View |
| Feb 4, 2026 | GHK-Cu | 98.9 % | 114.2 mg of 100 mg (14 %) | Pass | View |
| Feb 4, 2026 | BPC-157 | 99.8 % | 13 mg of 10 mg (30 %) | Pass | View |
| Jan 22, 2026 | Retatrutide | 99.8 % | 29.7 mg of 20 mg (49 %) | Pass | View |
| Jan 15, 2026 | BPC-157 | 98.51 % | 4.12 mg of 4.97 mg (-17 %) | Pass | View |
| Jan 15, 2026 | GHK-Cu | 99.95 % | 44.2 mg of 50 mg (-12 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.37 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 99.8 % | 34.9 mg of 30 mg (16 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 99.9 % | 50.6 mg of 40 mg (27 %) | Pass | View |
| Jan 1, 2026 | Tirzepatide | 99.7 % | 22.6 mg of 20 mg (13 %) | Pass | View |
| Dec 17, 2025 | Retatrutide | 99.89 % | 9.46 mg of 10 mg (-5 %) | Pass | View |
| Dec 4, 2025 | Retatrutide | 99.5 % | 21.1 mg of 20 mg (6 %) | Pass | View |
| Nov 25, 2025 | Tirzepatide | 98.81 % | 20.7 mg of 20 mg (3 %) | Pass | View |
| Nov 25, 2025 | Retatrutide | 99.95 % | 9.77 mg of 10 mg (-2 %) | Pass | View |
| Nov 17, 2025 | Retatrutide | 99.07 % | 21.4 mg of 20 mg (7 %) | Pass | View |
What Hangzhou Mandy Biotechnology sells
No current listings on record.
About Hangzhou Mandy Biotechnology
Finnrick has tested 38 samples from Hangzhou Mandy Biotechnology across 4 products.